Clinical Trial Update: Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP) [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study evaluating combined prevention of sexually transmitted infections in men who have sex with men using TDF/F…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Sexually Transmitted Infections

Drugs mentioned

• TDF/FTC (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Unsafe Sex, Risk-Taking | Phase 3 | Status: COMPLETED